“Is there anything else you’d like to share about leukemia treatment?
I'm very excited because I think we’ll cure leukemia in my lifetime. We’ve already come so far. For example, before 2000, patients with Philadelphia chromosome-positive acute lymphoblastic leukemia had a survival rate of 10%. Targeted therapy improved that to 35% to 40%, but patients had to receive a stem cell transplant, which isn’t easy. But I’ve led research on a drug called ponatinib in combination with chemotherapy, and we’ve seen the survival rate jump to 80% without a transplant. Our next goal is to increase the survival rate to 90% and eliminate the need for chemotherapy by using a combination of targeted therapy and immunotherapy.”